| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,622 | 6,853 | 5,023 | 5,271 | | Cost of Revenue | 3,559 | 4,302 | 4,484 | 3,844 | | | Gross Profit | 4,063 | 2,551 | 539 | 1,427 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,404 | 2,617 | 2,523 | 3,101 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 512 | 471 | 2,273 | 1,143 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,146 | (537) | (4,257) | (2,817) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 173 | 830 | (926) | (36) | | Earnings Before Interest And Taxes | 1,319 | 293 | (5,183) | (2,853) | | Interest Expense | 469 | 310 | 484 | 297 | | Income Before Tax | 850 | (17) | (5,667) | (3,150) | | Income Tax Expense | 5 | 12 | 22 | 51 | | Minority Interest | (1,109) | (844) | 690 | (32) | | | | Net Income From Continuing Ops | (264) | (873) | (4,999) | (3,233) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (264) | (873) | (4,999) | (3,233) | | Preferred Stock And Other Adjustments |
-
| (34) | (33) | (34) | | | Net Income Applicable To Common Shares | ($264) | ($906) | ($5,032) | ($3,267) |
|
0.10% Nasdaq 0.00%
Income Statement
